NanoVation Therapeutics

NanoVation Therapeutics develops innovative lipid nanoparticle (LNP) technologies for nucleic acid delivery, overcoming limitations of existing approaches, particularly in targeting tissues outside the liver. Their lead technology, lcLNP™, enables functional nucleic acid delivery to extrahepatic cell types and shows improved therapeutic index in preclinical studies. The company partners with pharmaceutical and biotech firms to develop genetic medicines.

Buy Funded Startups lists

Funding Round:

Funding Amount:

Date: 19-Nov-2024

Investors: Convergent Ventures

Markets: Biotechnology, Pharmaceuticals, Genetic Medicines, Lipid Nanoparticle Technology, Nanotechnology, Therapeutics

HQ: Vancouver, British Columbia, Canada

Founded: 2020

Website: https://www.nanovationtx.com/

LinkedIn: https://www.linkedin.com/company/nanovationtx/

Twitter:

Instagram: